Article:
Antimicrobial resistance profile and molecular screening of blakpc gene among clinical isolates of pseudomonas aeruginosa from a Tertiary care hospital, Nepal

creativeworkseries.issnOnline ISSN: 2676-1424; Print ISSN: 2676-1319
dc.contributor.authorAdhikari, Ram Prasad
dc.contributor.authorKhanal, Laxmi Kant
dc.contributor.authorSapkota, Jyotshna
dc.contributor.authorPandey, Ritu
dc.contributor.authorSah, Anil Kumar
dc.contributor.authorKhadka, Shusila
dc.contributor.authorRai, Shiba Kumar
dc.creator.affiliationDepartment of Microbiology, Nepal Medical College Teaching Hospital, Attarkhel, Gokarneshwor-8, Kathmandu
dc.creator.affiliationDepartment of Microbiology, Nepal Medical College Teaching Hospital, Attarkhel, Gokarneshwor-8, Kathmandu
dc.creator.affiliationDepartment of Microbiology, Nepal Medical College Teaching Hospital, Attarkhel, Gokarneshwor-8, Kathmandu
dc.creator.affiliationDepartment of Microbiology, Nepal Medical College Teaching Hospital, Attarkhel, Gokarneshwor-8, Kathmandu
dc.creator.affiliationDepartment of Research, Annapurna Neuro Hospital, Maitighar, Kathmandu
dc.creator.affiliationDepartment of Microbiology, Nepal Medical College Teaching Hospital, Attarkhel, Gokarneshwor-8, Kathmandu
dc.creator.affiliationDepartment of Microbiology, Nepal Medical College Teaching Hospital, Attarkhel, Gokarneshwor-8, Kathmandu
dc.date.accessioned2026-10-06T09:10:39Z
dc.date.available2026-10-06T09:10:39Z
dc.date.issued2025
dc.description.abstractAbstract: Pseudomonas aeruginosa is a major opportunistic pathogen with increasing antimicrobial resistance, creating significant treatment challenges in hospital settings. This study aimed to determine the antimicrobial resistance profile of P. aeruginosa and screen for the blaKPC gene among meropenem-resistant isolates. A descriptive cross-sectional study was conducted from December 2021 to May 2022, yielding 75 non-duplicate isolates identified through standard microbiological methods; antimicrobial susceptibility testing was performed using the Kirby- Bauer technique, and 17 meropenem-resistant isolates underwent PCR for blaKPC detection. Sputum (33.33%) and pus (29.33%) were the most common specimen sources, and multidrug resistance was observed in 54.7% of isolates, particularly among inpatients and ICU cases. High-rate resistance to ceftazidime and piperacillin was noted, while carbapenem resistance remained moderate (21-23%). None of the meropenem-resistant isolates carried the blaKPC gene, indicating alternative carbapenem resistance mechanisms. These findings highlight a substantial burden of MDR P. aeruginosa and underscore the need for ongoing surveillance and strengthened infection control practices.
dc.identifier.doihttps://doi.org/10.3126/nmcj.v27i4.88112
dc.identifier.urihttps://hdl.handle.net/20.500.14572/7990
dc.language.isoen_US
dc.publisherNepal Medical College Pvt. Ltd.
dc.subjectPseudomonas aeruginosa
dc.subjectMDR
dc.subjectESBL
dc.subjectBlaKPC gene
dc.subjectNepal
dc.titleAntimicrobial resistance profile and molecular screening of blakpc gene among clinical isolates of pseudomonas aeruginosa from a Tertiary care hospital, Nepal
dc.typeArticle
dspace.entity.typePublication
local.article.typeOriginal Article
relation.isJournalIssueOfPublicationed2d47dc-a820-49e5-b38c-b04eed861dd9
relation.isJournalIssueOfPublication.latestForDiscoveryed2d47dc-a820-49e5-b38c-b04eed861dd9
relation.isJournalOfPublication865934c8-5e95-468c-8ca6-7bb2529e4064

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
325-31+Ram+Prasad+Adhikari.pdf
Size:
307.08 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections